[go: up one dir, main page]

WO2009056114A3 - Utilisation de poudres de polyéthylène-glycol et compositions contenant ces poudres - Google Patents

Utilisation de poudres de polyéthylène-glycol et compositions contenant ces poudres Download PDF

Info

Publication number
WO2009056114A3
WO2009056114A3 PCT/DE2008/001756 DE2008001756W WO2009056114A3 WO 2009056114 A3 WO2009056114 A3 WO 2009056114A3 DE 2008001756 W DE2008001756 W DE 2008001756W WO 2009056114 A3 WO2009056114 A3 WO 2009056114A3
Authority
WO
WIPO (PCT)
Prior art keywords
polyethylene glycol
compositions containing
same
powders
glycol powders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2008/001756
Other languages
German (de)
English (en)
Other versions
WO2009056114A2 (fr
Inventor
Michael Brock
Thorsten Kamp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sasol Germany GmbH
Original Assignee
Sasol Germany GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sasol Germany GmbH filed Critical Sasol Germany GmbH
Publication of WO2009056114A2 publication Critical patent/WO2009056114A2/fr
Publication of WO2009056114A3 publication Critical patent/WO2009056114A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

L'invention concerne l'utilisation de poudres de polyéthylène-glycol composées de particules sphériques de polyéthylène-glycol à répartition granulométrique étroite, et des compositions contenant ces poudres.
PCT/DE2008/001756 2007-11-02 2008-10-31 Utilisation de poudres de polyéthylène-glycol et compositions contenant ces poudres Ceased WO2009056114A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007052870A DE102007052870A1 (de) 2007-11-02 2007-11-02 Verwendung von Polyethylenglykol-Pulvern und Zusammensetzungen enthaltend diese
DE102007052870.3 2007-11-02

Publications (2)

Publication Number Publication Date
WO2009056114A2 WO2009056114A2 (fr) 2009-05-07
WO2009056114A3 true WO2009056114A3 (fr) 2009-07-09

Family

ID=40445580

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2008/001756 Ceased WO2009056114A2 (fr) 2007-11-02 2008-10-31 Utilisation de poudres de polyéthylène-glycol et compositions contenant ces poudres

Country Status (2)

Country Link
DE (1) DE102007052870A1 (fr)
WO (1) WO2009056114A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
MY193378A (en) 2012-09-11 2022-10-07 Norgine Bv Compositions comprising peg and ascorbate
DE102015001915B4 (de) * 2015-02-16 2016-12-22 Clariant International Ltd. Verwendung von Polyethylenglykol als Dekorationsmaterial, insbesondere Kunstschnee
RU2019143354A (ru) * 2017-05-30 2021-06-30 Юджин Й. ЧАНЬ Флуорогенные пептидные субстраты для измерений фактора ха в растворе и твердой фазе

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461546B1 (en) * 1998-08-03 2002-10-08 Ut-Battelle Apparatus for and method of producing monodisperse submicron polymer powders from solution
EP1563973A1 (fr) * 2004-02-11 2005-08-17 Clariant GmbH Polyethylène glycol solide et pulvérulent ayant une répartition de particules bimodale, sa préparation et son utilisation
CN101036668A (zh) * 2007-02-15 2007-09-19 刘宇 含有聚乙二醇4000的颗粒剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0816061B2 (ja) * 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
DE19617924A1 (de) 1996-05-05 1997-11-13 Brace Gmbh Chemie Plastics Dat Verfahren und Vorrichtung zur Schwingungsanregung von flüssigen Medien bei der Herstellung von sphärischen Granulaten
JP4655349B2 (ja) * 2000-10-18 2011-03-23 日油株式会社 経口医薬用ポリエチレングリコールおよびその製造方法
JP5041642B2 (ja) * 2001-08-30 2012-10-03 日本製薬株式会社 経口腸管洗浄液用組成物及び経口腸管洗浄液用充填製剤
WO2004089343A1 (fr) * 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Comprimes hydrosolubles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461546B1 (en) * 1998-08-03 2002-10-08 Ut-Battelle Apparatus for and method of producing monodisperse submicron polymer powders from solution
EP1563973A1 (fr) * 2004-02-11 2005-08-17 Clariant GmbH Polyethylène glycol solide et pulvérulent ayant une répartition de particules bimodale, sa préparation et son utilisation
CN101036668A (zh) * 2007-02-15 2007-09-19 刘宇 含有聚乙二醇4000的颗粒剂

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BLATTNER D ET AL: "PERCOLATION THEORY AND COMPACTIBILITY OF BINARY POWDER SYSTEMS", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS, NEW YORK, NY, US, vol. 7, no. 2, 1 February 1990 (1990-02-01), pages 113 - 117, XP008104361, ISSN: 0724-8741, [retrieved on 20041124] *
ROWE R C ET AL: "Polyethylene glycol", HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, LONDON : PHARMACEUTICAL PRESS.; GB, 1 January 2006 (2006-01-01), pages 548 - 549, XP002520824, ISBN: 978-1-58212-058-4 *

Also Published As

Publication number Publication date
DE102007052870A1 (de) 2009-05-07
WO2009056114A2 (fr) 2009-05-07

Similar Documents

Publication Publication Date Title
IL257382B (en) Nucleic acid-lipid particles, preparations containing them and their uses
WO2012035283A8 (fr) Composition pharmaceutique
IL208744A0 (en) Nucleic acid-lipid particles, compositions comprising the same and uses thereof
WO2010084480A3 (fr) Particules de distribution
WO2010079467A3 (fr) Particules de distribution
WO2010079466A3 (fr) Particules de distribution
WO2010079468A3 (fr) Particules de distribution
WO2012068105A3 (fr) Compositions et leurs utilisations pour convertir des contaminants
WO2011130671A3 (fr) Compositions de revêtement pour des articles d'emballage et procédés de revêtement
WO2015051054A3 (fr) Particule de distribution contenant un agent bénéfique
EP1940422A4 (fr) Particules revetues d'oxyde de zinc, compositions les contenant et procedes de fabrication de celles-ci
WO2009101593A3 (fr) Particule d'administration
WO2010014172A3 (fr) Particule de vectorisation
WO2007099469A3 (fr) Particule pour libération contenant un agent avantageux
WO2012024526A3 (fr) Conjugués, particules, compositions et procédés associés
GEP20156230B (en) Forms of rifaximin and usage thereof
WO2010068471A3 (fr) Compositions d'hygiène bucco-dentaire pour dents sensibles
WO2011060099A3 (fr) Compositions d'écran solaire incluant des particules de phosphate de calcium uniformes, rigides, sphériques, nanoporeuses et leurs méthodes de fabrication et d'utilisation
IL226023A0 (en) Antibodies against 5dr, preparations containing them and their uses
SI2029480T1 (sl) Biološko aktivni nanodelci karbonatno substituiranega hidroksiapatita, postopek za njihovo pripravo in sestavki, ki jih vključujejo
WO2008150537A3 (fr) Particules de silice et ses procédés de production et d'utilisation
EP2571486A4 (fr) Composition d'inhalation à poudre sèche
EG25372A (en) Device for characterizing the particle size distribution of powders and its uses.
WO2010002613A3 (fr) Procédé de fabrication d’une composition pharmaceutique en poudre sèche
WO2009039157A3 (fr) Formulations pharmaceutiques d'orlistat

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08845383

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase

Ref document number: 08845383

Country of ref document: EP

Kind code of ref document: A2